60 vegetarian capsules, Item# 01828
|Units||Non-Members||Members (Not a Member?)|
Safely managing blood lipid levels can be a challenge for people as they get older. Yet an increasing number of doctors recognize the critical need to protect the arterial wall against low-density lipoprotein (LDL) oxidation and inflammatory insults.
For those who want to maintain healthful levels of lipids in the blood, Advanced Lipid Control contains two powerful ingredients that help protect key aspects of cardiovascular function: black tea theaflavins and Indian gooseberry. A staple beverage in many cultures for millennia, black tea contains theaflavins, beneficial flavonoids found naturally in its dried leaves. Scientists have discovered that these theaflavins provide multiple benefits for arterial health. As well as supporting healthy cholesterol levels already within normal range1, theaflavins have been shown in human studies to protect against LDL oxidation1 and favorably affect endothelial function2, thus helping to maintain a healthy circulation.
Scientists have also found that black tea flavonoids possess strong antioxidant properties, which can help mitigate oxidative damage to cells and tissues from free radicals.3 In addition, theaflavins have been found to be helpful in regulating key inflammatory mediators in the body, thus helping to preserve endothelial integrity.4,5
Advanced Lipid Control now contains Capros® amla, an extract of Indian gooseberry. This standardized extract contains tannins that have been shown to improve endothelial function and safely help maintain healthy levels of all three key blood lipids — LDL, high-density lipoprotein (HDL), and triglycerides — as well as C-reactive protein.6
This special formula supports healthy cholesterol levels already within normal range and safeguards vascular and heart health while providing excellent antioxidant protection.
1. J Nutr. 2003;133:3298S-3302S.
2. Zhong Yao Cai. 2005 Apr;28(4):304-6.
3. Prev Med. 2005;40:910-8.
4. Folia Biol (Praha). 2007;53(5):164-72.
5. Crit Care Med. 2004;32:2097-103.
6. Diabetes Metab Syndr Obes. 2013 Jul 26;6:275-84.
Capros® is a registered trademark of Natreon, Inc..
|Dosage and Use|